Synthetic cannabinoids further rift between marijuana and hemp industries

MJBizDaily
By Chris CasacchiaMar 13, 2023, 10:30 am180 pts
A recent ruling from the U.S. Drug Enforcement Administration classifying a synthetic cannabinoid as a Schedule 1 drug has furthered the ire between the licensed cannabis industry and the largely unregulated cannabinoid sector, which has grown into a multi-billion market amid the proliferation of CBD and…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

US House Committee Approves Bill to Close THCA ‘Loophole,’ Ban Intoxicating Hemp Products 44

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.